Ryman Healthcare Group Ltd. buy tbackenh
Start price
13.07.21
/
80%
€7.98
Target price
13.07.22
€10.00
Performance (%)
-31.03%
End price
13.07.22
€5.50
Summary
This prediction ended on 13.07.22 with a price of €5.50. Massive losses of -31.03% were the result for the BUY prediction by tbackenh. tbackenh has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Ryman Healthcare Group Ltd. | 6.093% | 6.093% | -26.629% | -67.593% |
iShares Core DAX® | 2.821% | -1.953% | 15.071% | 11.862% |
iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% | 40.075% |
iShares Nikkei 225® | 3.687% | -4.221% | 14.286% | 6.629% |
iShares S&P 500 | 3.577% | -2.240% | 25.546% | 38.398% |
According to tbackenh what are the pros and cons of Ryman Healthcare Group Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management
Some uniques
Known brand
Top 10 in its market
Future proof or reliable business model
Cons
Comments by tbackenh for this prediction
In the thread Ryman Healthcare Group Ltd. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Ryman Healthcare Group Ltd.
Die von tbackenh gewählte maximale Laufzeit wurde überschritten
Stopped prediction by tbackenh for Ryman Healthcare Group Ltd.
Ryman Healthcare Group Ltd.
Start price
Target price
Perf. (%)
€6.82
27.05.19
27.05.19
€7.75
08.07.19
08.07.19
6.01%
08.07.19
08.07.19
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management